Porcine Heparin
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Heparin Injection Market Research Report 2023
1 Heparin Injection Market Overview
1.1 Product Overview and Scope of Heparin Injection
1.2 Heparin Injection Segment by Type
1.2.1 Global Heparin Injection Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 1,000 USP/mL
1.2.3 5,000 USP/mL
1.2.4 10,000 USP/mL
1.2.5 20,000 USP/mL
1.3 Heparin Injection Segment by Application
1.3.1 Global Heparin Injection Sales Comparison by Application: (2022-2028)
1.3.2 Thrombosis,
1.3.3 Pulmonary Embolism
1.3.4 Hemodialysis
1.3.5 Others
1.4 Global Heparin Injection Market Size Estimates and Forecasts
1.4.1 Global Heparin Injection Revenue 2017-2028
1.4.2 Global Heparin Injection Sales 2017-2028
1.4.3 Heparin Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Heparin Injection Market Competition by Manufacturers
2.1 Global Heparin Injection Sales Market Share by Manufacturers (2017-2022)
2.2 Global Heparin Injection Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Heparin Injection Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Heparin Injection Manufacturing Sites, Area Served, Product Type
2.5 Heparin Injection Market Competitive Situation and Trends
2.5.1 Heparin Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Heparin Injection Players Market Share by Revenue
2.5.3 Global Heparin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin Injection Retrospective Market Scenario by Region
3.1 Global Heparin Injection Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Heparin Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Heparin Injection Market Facts & Figures by Country
3.3.1 North America Heparin Injection Sales by Country
3.3.2 North America Heparin Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Heparin Injection Market Facts & Figures by Country
3.4.1 Europe Heparin Injection Sales by Country
3.4.2 Europe Heparin Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Heparin Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Heparin Injection Sales by Region
3.5.2 Asia Pacific Heparin Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Heparin Injection Market Facts & Figures by Country
3.6.1 Latin America Heparin Injection Sales by Country
3.6.2 Latin America Heparin Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Heparin Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Heparin Injection Sales by Country
3.7.2 Middle East and Africa Heparin Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Heparin Injection Historic Market Analysis by Type
4.1 Global Heparin Injection Sales Market Share by Type (2017-2022)
4.2 Global Heparin Injection Revenue Market Share by Type (2017-2022)
4.3 Global Heparin Injection Price by Type (2017-2022)
5 Global Heparin Injection Historic Market Analysis by Application
5.1 Global Heparin Injection Sales Market Share by Application (2017-2022)
5.2 Global Heparin Injection Revenue Market Share by Application (2017-2022)
5.3 Global Heparin Injection Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Inc Heparin Injection Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Wellona Pharma
6.2.1 Wellona Pharma Corporation Information
6.2.2 Wellona Pharma Description and Business Overview
6.2.3 Wellona Pharma Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Wellona Pharma Heparin Injection Product Portfolio
6.2.5 Wellona Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.3.4 B. Braun Heparin Injection Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Gland Pharma Limited
6.4.1 Gland Pharma Limited Corporation Information
6.4.2 Gland Pharma Limited Description and Business Overview
6.4.3 Gland Pharma Limited Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Gland Pharma Limited Heparin Injection Product Portfolio
6.4.5 Gland Pharma Limited Recent Developments/Updates
6.5 Sagent Pharmaceuticals, Inc
6.5.1 Sagent Pharmaceuticals, Inc Corporation Information
6.5.2 Sagent Pharmaceuticals, Inc Description and Business Overview
6.5.3 Sagent Pharmaceuticals, Inc Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sagent Pharmaceuticals, Inc Heparin Injection Product Portfolio
6.5.5 Sagent Pharmaceuticals, Inc Recent Developments/Updates
6.6 Stanex
6.6.1 Stanex Corporation Information
6.6.2 Stanex Description and Business Overview
6.6.3 Stanex Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Stanex Heparin Injection Product Portfolio
6.6.5 Stanex Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Mylan Heparin Injection Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Rewine Pharmaceutical
6.8.1 Rewine Pharmaceutical Corporation Information
6.8.2 Rewine Pharmaceutical Description and Business Overview
6.8.3 Rewine Pharmaceutical Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Rewine Pharmaceutical Heparin Injection Product Portfolio
6.8.5 Rewine Pharmaceutical Recent Developments/Updates
6.9 Shenzhen Techdow Pharmaceutical Co., Ltd
6.9.1 Shenzhen Techdow Pharmaceutical Co., Ltd Corporation Information
6.9.2 Shenzhen Techdow Pharmaceutical Co., Ltd Description and Business Overview
6.9.3 Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Product Portfolio
6.9.5 Shenzhen Techdow Pharmaceutical Co., Ltd Recent Developments/Updates
7 Heparin Injection Manufacturing Cost Analysis
7.1 Heparin Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Heparin Injection
7.4 Heparin Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Heparin Injection Distributors List
8.3 Heparin Injection Customers
9 Heparin Injection Market Dynamics
9.1 Heparin Injection Industry Trends
9.2 Heparin Injection Market Drivers
9.3 Heparin Injection Market Challenges
9.4 Heparin Injection Market Restraints
10 Global Market Forecast
10.1 Heparin Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Heparin Injection by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Heparin Injection by Type (2023-2028)
10.2 Heparin Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Heparin Injection by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Heparin Injection by Application (2023-2028)
10.3 Heparin Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Heparin Injection by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Heparin Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Heparin Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Heparin Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Heparin Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Heparin Injection Market Competitive Situation by Manufacturers in 2021
Table 5. Global Heparin Injection Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Heparin Injection Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Heparin Injection Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Heparin Injection Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Heparin Injection Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Heparin Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Heparin Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Heparin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin Injection as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Heparin Injection Sales by Region (2017-2022) & (K Units)
Table 16. Global Heparin Injection Sales Market Share by Region (2017-2022)
Table 17. Global Heparin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Heparin Injection Revenue Market Share by Region (2017-2022)
Table 19. North America Heparin Injection Sales by Country (2017-2022) & (K Units)
Table 20. North America Heparin Injection Sales Market Share by Country (2017-2022)
Table 21. North America Heparin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Heparin Injection Revenue Market Share by Country (2017-2022)
Table 23. Europe Heparin Injection Sales by Country (2017-2022) & (K Units)
Table 24. Europe Heparin Injection Sales Market Share by Country (2017-2022)
Table 25. Europe Heparin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Heparin Injection Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Heparin Injection Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Heparin Injection Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Heparin Injection Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Heparin Injection Revenue Market Share by Region (2017-2022)
Table 31. Latin America Heparin Injection Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Heparin Injection Sales Market Share by Country (2017-2022)
Table 33. Latin America Heparin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Heparin Injection Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Heparin Injection Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Heparin Injection Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Heparin Injection Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Heparin Injection Revenue Market Share by Country (2017-2022)
Table 39. Global Heparin Injection Sales by Type (2017-2022) & (K Units)
Table 40. Global Heparin Injection Sales Market Share by Type (2017-2022)
Table 41. Global Heparin Injection Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Heparin Injection Revenue Share by Type (2017-2022)
Table 43. Global Heparin Injection Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Heparin Injection Sales (K Units) by Application (2017-2022)
Table 45. Global Heparin Injection Sales Market Share by Application (2017-2022)
Table 46. Global Heparin Injection Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Heparin Injection Revenue Share by Application (2017-2022)
Table 48. Global Heparin Injection Price by Application (2017-2022) & (USD/Unit)
Table 49. Pfizer Inc Corporation Information
Table 50. Pfizer Inc Description and Business Overview
Table 51. Pfizer Inc Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer Inc Heparin Injection Product
Table 53. Pfizer Inc Recent Developments/Updates
Table 54. Wellona Pharma Corporation Information
Table 55. Wellona Pharma Description and Business Overview
Table 56. Wellona Pharma Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Wellona Pharma Heparin Injection Product
Table 58. Wellona Pharma Recent Developments/Updates
Table 59. B. Braun Corporation Information
Table 60. B. Braun Description and Business Overview
Table 61. B. Braun Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. B. Braun Heparin Injection Product
Table 63. B. Braun Recent Developments/Updates
Table 64. Gland Pharma Limited Corporation Information
Table 65. Gland Pharma Limited Description and Business Overview
Table 66. Gland Pharma Limited Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Gland Pharma Limited Heparin Injection Product
Table 68. Gland Pharma Limited Recent Developments/Updates
Table 69. Sagent Pharmaceuticals, Inc Corporation Information
Table 70. Sagent Pharmaceuticals, Inc Description and Business Overview
Table 71. Sagent Pharmaceuticals, Inc Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Sagent Pharmaceuticals, Inc Heparin Injection Product
Table 73. Sagent Pharmaceuticals, Inc Recent Developments/Updates
Table 74. Stanex Corporation Information
Table 75. Stanex Description and Business Overview
Table 76. Stanex Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Stanex Heparin Injection Product
Table 78. Stanex Recent Developments/Updates
Table 79. Mylan Corporation Information
Table 80. Mylan Description and Business Overview
Table 81. Mylan Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Mylan Heparin Injection Product
Table 83. Mylan Recent Developments/Updates
Table 84. Rewine Pharmaceutical Corporation Information
Table 85. Rewine Pharmaceutical Description and Business Overview
Table 86. Rewine Pharmaceutical Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Rewine Pharmaceutical Heparin Injection Product
Table 88. Rewine Pharmaceutical Recent Developments/Updates
Table 89. Shenzhen Techdow Pharmaceutical Co., Ltd Corporation Information
Table 90. Shenzhen Techdow Pharmaceutical Co., Ltd Description and Business Overview
Table 91. Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Product
Table 93. Shenzhen Techdow Pharmaceutical Co., Ltd Recent Developments/Updates
Table 94. Production Base and Market Concentration Rate of Raw Material
Table 95. Key Suppliers of Raw Materials
Table 96. Heparin Injection Distributors List
Table 97. Heparin Injection Customers List
Table 98. Heparin Injection Market Trends
Table 99. Heparin Injection Market Drivers
Table 100. Heparin Injection Market Challenges
Table 101. Heparin Injection Market Restraints
Table 102. Global Heparin Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 103. Global Heparin Injection Sales Market Share Forecast by Type (2023-2028)
Table 104. Global Heparin Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 105. Global Heparin Injection Revenue Market Share Forecast by Type (2023-2028)
Table 106. Global Heparin Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 107. Global Heparin Injection Sales Market Share Forecast by Application (2023-2028)
Table 108. Global Heparin Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 109. Global Heparin Injection Revenue Market Share Forecast by Application (2023-2028)
Table 110. Global Heparin Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 111. Global Heparin Injection Sales Market Share Forecast by Region (2023-2028)
Table 112. Global Heparin Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 113. Global Heparin Injection Revenue Market Share Forecast by Region (2023-2028)
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Heparin Injection
Figure 2. Global Heparin Injection Market Share by Type in 2021 & 2028
Figure 3. 1,000 USP/mL Product Picture
Figure 4. 5,000 USP/mL Product Picture
Figure 5. 10,000 USP/mL Product Picture
Figure 6. 20,000 USP/mL Product Picture
Figure 7. Global Heparin Injection Market Share by Application in 2021 & 2028
Figure 8. Thrombosis,
Figure 9. Pulmonary Embolism
Figure 10. Hemodialysis
Figure 11. Others
Figure 12. Global Heparin Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Heparin Injection Market Size (2017-2028) & (US$ Million)
Figure 14. Global Heparin Injection Sales (2017-2028) & (K Units)
Figure 15. Heparin Injection Sales Share by Manufacturers in 2021
Figure 16. Global Heparin Injection Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Heparin Injection Players: Market Share by Revenue in 2021
Figure 18. Heparin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Heparin Injection Sales Market Share by Region (2017-2022)
Figure 20. Global Heparin Injection Sales Market Share by Region in 2021
Figure 21. Global Heparin Injection Revenue Market Share by Region (2017-2022)
Figure 22. Global Heparin Injection Revenue Market Share by Region in 2021
Figure 23. U.S. Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Taiwan Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Philippines Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Vietnam Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Mexico Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Brazil Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Argentina Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Turkey Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Saudi Arabia Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. U.A.E Heparin Injection Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Sales Market Share of Heparin Injection by Type (2017-2022)
Figure 48. Manufacturing Cost Structure of Heparin Injection
Figure 49. Manufacturing Process Analysis of Heparin Injection
Figure 50. Heparin Injection Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Inc Wellona Pharma B. Braun Gland Pharma Limited Sagent Pharmaceuticals, Inc Stanex Mylan Rewine Pharmaceutical Shenzhen Techdow Pharmaceutical Co., Ltd